nothing is more fun than reality
Welcome to Checkpoint Investments

May we suggest turning on your speakers for added pleasure

Checkpoint Investments is our project to earn income and at the same time make investments that contribute to make the world a better place to live. Our focus is in new software, biotech/pharma, advanced technology and cutting edge green projects.

IMPORTANT We are not investment advisors and do not make any claim that our investments will make money. Our investments are in small cap companies which generally can be classified as having a High Risk.

For the sake of disclosure and transparency, this division of Bravo Oh Yea Inc. has been and is a source of income, so we are showing our current investments. As these our exchange listed companies
we may at anytime sell or purchase stock at any time.

SEAC SEACHANGE INTERNATIONAL INC (NASDAQ)

SeaChange International (NASDAQ: SEAC) powers hundreds of cloud and on-premises platforms with live TV and video on demand (VOD) for more than 50 million subscribers worldwide. SeaChange’s end-to-end solution enables operators and content owners to cost-effectively launch a direct-to-consumer video service

CXM SPRINKLR INC (NYSE)

Sprinklr’s social media automation solutions help you ensure that every customer conversation on 30+ digital channels is on-schedule, on-brand, and on-target. The Sprinklr Unified-CXM platform enables thousands of the world’s largest enterprises use to market, advertise, research, care, and engage consumers.

IKT INHIBIKASE THERAPEUTICS INC (NASDAQ)

A pharmaceutical company innovating small-molecule kinase inhibitor therapeutics to treat Parkinson’s disease, other neurodegenerative diseases and neurological infections.

FWTC.VN FORWARD WATER TECHNOLOGIES CORP (TSXV)

Accelerating the world’s transition to clean water sustainably. Patented technology to REDUCE (up to 95% volume reduction), REUSE (up to 95% water recovery and RECOVER (up to 20x concentration.

Zymeworks Inc (NASDAQ)

Zymeworks Inc. develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases based upon the company’s molecular modelling software for optimizing protein structure.